The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma

Purpose: Inter-tumoral heterogeneity at the differential lesion level raises the possibility of distinct organ-specific responses to immune checkpoint inhibitors (ICIs). We aimed to comprehensively examine the clinicopathological factors to predict and assess the efficacy of nivolumab, programmed ce...

Full description

Bibliographic Details
Main Authors: Han Sang Kim, Chang Gon Kim, Jung Yong Hong, Il-hwan Kim, Beodeul Kang, Sanghoon Jung, Chan Kim, Sang Joon Shin, Hye Jin Choi, Jaekyung Cheon, Hong Jae Chon, Ho Yeong Lim
Format: Article
Language:English
Published: SAGE Publishing 2022-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221113266

Internet

https://doi.org/10.1177/17588359221113266

Similar Items